Urinary steroids at time of surgery in postmenopausal women with breast cancer

Breast Cancer Research and Treatment

Volumn 44, Issue 1, 1997, Pages 83-89

  Juricskay, Susan ^a   Szabó, István ^b   Kett, Károly ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Hungarian Academy of Sciences   (Hungary)

Author keywords

Breast cancer; Capillary gas chromatography; Postmenopausal women; Urine steroids

Indexed keywords

ANDROGEN; CORTOLONE; PRASTERONE SULFATE; PREGNANEDIOL; STEROID; TESTOSTERONE; TETRAHYDROCORTISOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CAPILLARY GAS CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; METABOLITE; POSTMENOPAUSE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STEROID URINE LEVEL; TESTOSTERONE BLOOD LEVEL;

EID: 0030887526     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005749032226     Document Type: Article

References (29)

1. Henderson IC, Cannelos GP: Cancer of the breast: the last decade. New Engl J Med 302: 17-30, 1980
2. Mousavi Y, Adlercreutz H: Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Molec Biol 41: 615-619, 1992
3. Pasqualini JR: Role of androgens in breast cancer. J Steroid Biochem Molec Biol 45: 1-3, 1993
4. Bernstein L, Ross RK: Endogenous hormones and breast cancer risk. Epidemiol Rev 15: 48-65, 1993
5. 5-steroids in tumorgenesis. Int J Cancer 50: 854-858, 1992
6. Boccuzzi G, Brignardello E, Dimonaco M, Forte C, Leonardi L, Pizzini A: Influence of dehydroepiandrosterone and 5-en-androstene-3β, 17β-diol on the growth of MCF-7 human breast cancer cells induced by 17-β-estradiol. Anticancer Res 12: 799-803, 1992
7. Gordon GB, Bush TL, Helzlsouer KJ, Miller SR, Comstock GW: Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res 50: 3859-3862, 1990
8. Zumoff B, Levin J, Rosenfeld RS, Jarkham M, Strain GW, Fukusima DK: Abnormal 24-hr mean plasma concentration of dehydroepiandrostene and dehydroepiandrosterone sulfate in women with primary operable breast cancer. Cancer Res 41: 3360-3363, 1981
9. Key TJA, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29-43, 1988
10. 2-glycoprotein messenger RNA in human breast cancer cells. Breast Cancer Res and Treat 29: 247-258, 1994
11. Ballerini P, Oriana S, Duca P, Martinetti A, Venturelli E, Ferrari L, Dolci S, Secreto G: Urinary testosterone as a marker of risk of recurrence in operable breast cancer. Breast Cancer Res Treat 26: 1-6, 1993
12. Fan C, Shuöshi W, Qing-tai D, Li-ying X, Wan-ying L, Wenxiu Y, Zhen-guo W: A study on plasma sex hormone levels in patients with breast cancer. Chinese Med J 98: 507-510, 1985
13. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377, 1957
14. Shackleton C, Honour J: Simultaneous estimation of urinary steroids by semi-automated gas chromatography. Investigation of neonatal infants and children with abnormal steroid synthesis. Clin Chim Acta 69: 267-283, 1976
15. Homoki J, Rodens K, Teller W: Infantile spasm: Urinary steroid excretion during corticotropin (ACTH) treatment. Proc Symp Anal Steroids. Sopron, Hungary, 1987
16. Hackenberg R, Turgetto I, Filmer A, Schulz KD: Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3β, 17β-diol in human mammary cancer cells. J Steroid Biochem Molec Biol 46: 597-603, 1993
17. Liberato MH, Sonohara S, Brentani MM: Effects of androgens on proliferation and progesterone receptor levels in T47D human breast cancer cells. Tumor Bio 14: 38-45, 1993
18. Pizzini A, Brignardello E, Leonardi L, Di Monaco G: Aromatase fails to mediate the proliferative effects of adrenal androgens on cultured MCF-7 breast cancer cells. Intern J Oncol 1: 708-712, 1992
19. Li SM, Yan X, Belanger A, Labrie F: Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(A) anthracene (DMBA) in the rat. Breast Cancer Res Treat 29: 203-217, 1994
20. Hill P, Garbaczewsi I, Kasumi F: Plasma testosterone and breast cancer. Eur J Cancer 21: 1265-1266, 1985
21. McFadyen IJ, Forrest APM, Prescott RJ, Groom GV, Golder MP, Fahmy DR: Circulating hormone concentrations in women with breast cancer. Lancer I: 1100-1102, 1976
22. Secreto G, Toniolo P, Berrino F, Recchione C, Cavalleri A, Pisani P, Totis A, Fariselli G, Di Pietri S: Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res 51: 2572-2576, 1991
23. Helzlsouer KJ, Gordon GB, Alberg AJ, Bush TL, Comstock GW: Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res 52: 1-4, 1992
24. Barrett-Connor E, Friedlander NJ, Khaw KT: Dehydroepiandrosterone sulfate and breast cancer risk. Cancer Res 50: 6571-6574, 1990
25. Bulbrook RD, Hayward JL, Spicer CC: Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet 2: 395-398, 1971
26. Adlercreutz H, Hämäläinen E, Gorbach SL, Goldin BR, Woods MN, Dwyer JT: Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. Am J Clin Nutr 49: 433-442, 1989
27. Secreto G, Recchione C, Cavalleri A, Miraglia M, Dati V: Circulating levels of testosterone, 17β-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients. Br J Cancer 47: 269-273, 1983
28. Badwe RA, Wang DY, Gregory WM, Fentiman IS, Chaudary MA, Smith P, Richards MA, Rubens RD: Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur J Cancer 30A: 445-448, 1994
29. Plu-Bureau G, Le MG, Sitruk-Ware R, Thalabard JC, Mauvais-Jarvis P: Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease. Br J Cancer 70: 270-277, 1994